Search
Cardio Diagnostics Holdings Inc
CDIOWAdd to Watchlist
0.015USD
+0.003+25.00%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of Cardio Diagnostics Holdings Inc Company
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Cardio Diagnostics Holdings Inc Info
Ticker SymbolCDIOW
Company nameCardio Diagnostics Holdings Inc
IPO dateNov 23, 2021
CEODr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
Address311 W. Superior Street
CityCHICAGO
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code60645
Phone18552269991
Website
Ticker SymbolCDIOW
IPO dateNov 23, 2021
CEODr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Company Executives of Cardio Diagnostics Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
--
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Peter K. Fung
Mr. Peter K. Fung
Independent Director
Independent Director
--
--
Mr. Paul F. Burton, J.D.
Mr. Paul F. Burton, J.D.
Independent Director
Independent Director
--
--
Ms. Wendy J. Betts
Ms. Wendy J. Betts
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
--
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
12
726.58K
0.00%
--
2026Q1
18
667.92K
0.00%
-720.60K
2025Q4
21
730.35K
0.00%
-622.32K
2025Q3
22
726.58K
0.00%
+121.27K
2025Q2
22
605.31K
0.00%
+24.34K
2025Q1
21
580.97K
0.00%
-805.01K
2024Q4
27
580.02K
0.00%
-388.74K
2024Q3
29
968.76K
0.00%
+35.91K
2024Q2
31
932.85K
0.00%
-265.62K
2024Q1
31
1.20M
0.00%
-1.20M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Walleye Trading, LLC
--
0%
-132.26K
-100.00%
Dec 31, 2024
Susquehanna International Group, LLP
--
0%
-53.25K
-100.00%
Dec 31, 2025
Citadel Advisors LLC
--
0%
-11.63K
-100.00%
Dec 31, 2024
UBS Financial Services, Inc.
3.92K
0%
+3.77K
+2497.35%
Dec 31, 2025
Walleye Capital LLC
--
0%
-234.91K
-100.00%
Dec 31, 2024
Clear Street Group Inc
82.44K
0%
-200.00
-0.24%
Dec 31, 2025
Two Sigma Investments, LP
--
0%
-10.53K
-100.00%
Dec 31, 2025
TD Securities, Inc.
--
0%
-100.00
-100.00%
Dec 31, 2025
Saba Capital Management, L.P.
199.84K
0%
--
--
Dec 31, 2025
Clear Street LLC
82.74K
0%
+100.00
+0.12%
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
